AdaptHealth (AHCO) CTO Albert Prast receives 63,449 restricted stock units in Form 4

Rhea-AI Filing Summary

AdaptHealth Corp.'s Chief Technology Officer, Albert A. Prast, reported an equity award in the form of restricted stock units. On January 30, 2026, he acquired 63,449 shares of common stock at $0 per share, representing restricted stock units that will settle in common stock upon vesting. Following this grant, he beneficially owned 442,907 shares of AdaptHealth common stock in direct ownership.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Prast Albert A.

(Last) (First) (Middle)

C/O ADAPTHEALTH LLC

555 EAST NORTH LANE, SUITE 5075

(Street)

CONSHOHOCKEN PA 19428

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AdaptHealth Corp. [ AHCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Technology Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/30/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/30/2026		A		63,449(1)	A	$0	442,907	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares represent restricted stock units and will be settled in common stock upon vesting.

Remarks:

*** The Power of Attorney given by the reporting person was previously filed with the U.S. Securities and Exchange Commission on February 4, 2025 as an exhibit to the Form 4 filed by the reporting person with respect to the Issuer and is hereby incorporated by reference.

	/s/ Richard Rew, as attorney-in-fact for Albert Prast	02/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did AdaptHealth (AHCO) report for Albert Prast?

AdaptHealth’s Chief Technology Officer, Albert A. Prast, reported acquiring 63,449 shares of common stock as a restricted stock unit grant. The units were issued at $0 per share and will convert into common stock when they vest, increasing his direct beneficial ownership.

When did the reported AdaptHealth (AHCO) insider transaction occur?

The insider transaction took place on January 30, 2026. On that date, Chief Technology Officer Albert A. Prast received 63,449 restricted stock units, which will be settled in AdaptHealth common stock upon vesting, as disclosed in the Form 4 filing.

How many AdaptHealth (AHCO) shares does Albert Prast own after this Form 4?

After the reported transaction, Albert A. Prast beneficially owned 442,907 shares of AdaptHealth common stock. This figure reflects his direct ownership following the grant of 63,449 restricted stock units that will settle in shares when they vest.

What type of equity was granted to AdaptHealth (AHCO) CTO Albert Prast?

Albert A. Prast received restricted stock units tied to AdaptHealth common stock. The Form 4 states these 63,449 units will be settled in common stock upon vesting, meaning he receives actual shares only after meeting the vesting conditions.

What was the price per share for Albert Prast’s AdaptHealth (AHCO) stock units?

The reported transaction lists a price of $0 per share for the 63,449 shares associated with the restricted stock units. This indicates the grant was an equity award, not an open-market purchase, and the units convert into common stock upon vesting.

Is the AdaptHealth (AHCO) insider transaction a sale or an acquisition?

The transaction is an acquisition of equity, not a sale. Chief Technology Officer Albert A. Prast was granted 63,449 restricted stock units, which will be settled in AdaptHealth common stock at vesting, increasing his direct beneficial ownership position.